{Reference Type}: Journal Article
{Title}: Antifungal drugs: New insights in research & development.
{Author}: Nicola AM;Albuquerque P;Paes HC;Fernandes L;Costa FF;Kioshima ES;Abadio AKR;Bocca AL;Felipe MS;
{Journal}: Pharmacol Ther
{Volume}: 195
{Issue}: 0
{Year}: 03 2019
{Factor}: 13.4
{DOI}: 10.1016/j.pharmthera.2018.10.008
{Abstract}: The need for better antifungal therapy is commonly accepted in view of the high mortality rates associated with systemic infections, the low number of available antifungal classes, their associated toxicity and the increasing number of infections caused by strains with natural or acquired resistance. The urgency to expand the range of therapeutic options for the treatment of fungal infections has led researchers in recent decades to seek alternative antifungal targets when compared to the conventional ones currently used. Although new potential targets are reported, translating the discoveries from bench to bedside is a long process and most of these drugs fail to reach the patients. In this review, we discuss the development of antifungal drugs focusing on the approach of drug repurposing and the search for novel drugs for classical targets, the most recently described gene targets for drug development, the possibilities of immunotherapy using antibodies, cytokines, therapeutic vaccines and antimicrobial peptides.